Latest Health stories from Life.
Strategic angle: Perfusion technology vastly improves organ quality in transplants, but high costs and coverage questions pose barriers in becoming the standard of care.
Strategic angle: Congress must pass bipartisan legislation to ensure Medicare coverage of breakthrough medical technologies, writes a physician and inventor.
Strategic angle: "Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer like that."
Strategic angle: It's Oscar season, so we're bringing you a special STATus report on how we'd cover the drug scandal in 'The Fugitive' if it were real.
Strategic angle: Cardiology groups say adults as young as 30 should assess cholesterol risk and consider treatment to prevent heart attacks and strokes.
Strategic angle: Virtually all (98.9%) of the 2.6 million Medicare beneficiaries enrolled in a Medicare Advantage plan that terminated coverage at the end of 2025 have at least one MA-PD available in 2026.
On this week's The Readout LOUD podcast: A friend of Jeffrey Epstein attempts a biotech comeback, and (another) Prasad FDA exit.
Strategic angle: Exploring the ongoing battle over drug pricing and the contrasting approaches of Trump and Biden.
This issue brief describes recent trends in the number of Medicaid outpatient prescriptions and the spending on those drugs and examines the implications of recent federal actions on future trends.
Strategic angle: Vaccine skepticism, FDA-authorized vape flavors, and more health news from Morning Rounds
Most Across Political Parties Want Government to Do More to Regulate Prices
Strategic angle: Trump is drawing more attention to his efforts to lower drug prices, like TrumpRx.
Strategic angle: New FDA guidance suggests mint, coffee, and spice vape flavors could be authorized, raising debate over toxic additives and youth vaping risks.
Strategic angle: The legal battle underscores the complicated questions surrounding how best to evaluate hospital safety.
Strategic angle: As Trump political advisers try to move on from vaccine policy debates, MAHA movement insiders push back, calling RFK Jr. supporters vital to GOP's success.
Strategic angle: Lobbying groups supported by insurance companies have criticized the research and promoted their own.
Strategic angle: An unexpected discovery may bring scientists closer to a long-sought goal: finding an ideal immunotherapy target for solid tumors.
Strategic angle: Exposure to gun violence can severely affect the mental health of children and adolescents.
Strategic angle: This brief analyzes the latest youth mortality data from the CDC, revealing alarming trends in firearm-related deaths among children and adolescents.
Strategic angle: BIO's Crowley warns U.S. risks losing lead, a familiar red flag with Aldeyra, and other biotech news from The Readout.